ORCL ORACLE CORP Insider Trading

Oracle EVP Stuart Levey sold 15,000 ORCL shares ($2.6M) at $176.19; exits 81.4% of holdings post-transaction.

Levey Stuart, Chief Legal Officer, sold 15,000 shares (15.0K shares) at $176.19 on 2026-04-16, reducing his ORCL holdings from 18,429 to 3,429 shares—an 81.4% reduction in position. His prior sell at this ticker on 2025-10-10 was followed by negative 90-day and 30-day returns (-36.8% and -20.2% respectively), suggesting a historical pattern of selling ahead of declines. Current conditions show the stock trading at $177.58, down -45.9% from its 52-week high of $328.33 but up 18.6% over the past 30 days. Oracle's fundamentals remain solid with $17.2B quarterly revenue, $3.7B net income, and +8.4% annual revenue growth, though the P/E of 31.49 reflects elevated valuation. The near-complete elimination of Levey's ORCL position warrants attention given the timing pattern in his prior trade history.

CEO Magouyrk sells 10,000 ORCL shares at $155.23; stock down 23.2% in 30 days, 27.8% in 90 days.

Magouyrk Clayton M., Chief Executive Officer of Oracle, sold 10,000 shares at $155.23 on 2026-02-09, reducing his holdings from 144,030 to 134,030 shares. The sale came as the stock has declined 23.2% over the prior 30 days and 27.8% over 90 days, trading at $157.16 currently versus a 52-week high of $328.33. Reviewing his same-ticker history at ORCL, 2 of his 3 prior measurable sells were well-timed, with the 2025-10-21 and 2025-09-12 sales followed by 90-day declines of 30.9% and 33.1% respectively, suggesting a pattern of selling before weakness. While current fundamentals remain solid (revenue $16.1B, net income $6.1B, annual growth of 8.4%), the CEO's continued sales during a sustained drawdown—particularly given the demonstrated pattern of prior well-timed exits at this ticker—merit investor attention to whether management views current valuations or near-term catalysts as unfavorable.

EVP Douglas Kehring sold 35,000 ORCL shares at $194.89 for $6.8M, cutting holdings by 51.0%

Douglas A. Kehring, EVP and Principal Financial Officer, executed a substantial sale of 35,000 shares at $194.89 on 2026-01-15, reducing his post-transaction holdings to 33,638 shares from 68,638 shares—a 51.0% reduction in his stake. The transaction occurred at $194.89, which is $3.80 above the current price of $191.09, placing it near recent trading levels despite the stock being -41.8% below its 52-week high of $328.33. Oracle's financial position remains strong with annual revenue growth of 8.4%, a market cap of $549.0B, and net income of $6.1B, though the elevated P/E of 35.58 suggests the market is pricing in significant future performance. The size and proportion of this sale—eliminating roughly half his position in a single trade—warrant attention to whether this reflects a material change in the executive's exposure to the company or a repositioning of his portfolio holdings.

President Global Field Operations Mark Hura sells 15,000 ORCL shares ($196.89) for $2,953,314

Mark Hura, President of Global Field Operations at Oracle, sold 15,000 shares at $196.89 on December 24, 2025, reducing his holdings by -6.0% from 249,077 to 234,077 shares. The sale occurred as Oracle stock trades at $195.38 current price, down -40.5% from the 52-week high of $328.33 and down -30.5% over the past 90 days. Oracle's fundamentals remain solid with quarterly revenue of $16,058,000,000 and net income of $6,135,000,000, supporting an annual revenue growth rate of +8.4% year-over-year and a market cap of $561,352,139,400. The transaction's modest scale relative to Hura's remaining holdings and Oracle's substantial financial position suggests routine portfolio activity rather than a major directional signal.

CEO Magouyrk sold 10,000 ORCL shares at $192.52 on 2025-12-19 (total $1.9M); stock down -36.7% in 90 days post-sale.

Magouyrk Clayton M., Chief Executive Officer, sold 10,000 shares at $192.52, reducing holdings from 154,030 to 144,030 shares (-6.5%). At the transaction price, the stock has since fallen to $195.34 (current), but critically, the 90-day price action from the sale date through the end of the measurement period shows a -36.7% decline. His prior ORCL sales (three prior trades at this ticker) show mixed timing: the 2025-09-12 sale was well-timed (followed by -33.1% over 90 days), while the 2025-06-17 sale proved poorly timed (+41.1% over 90 days). His cross-ticker track record across all holdings shows 3 prior sells with a 50.00% well-timed rate at the 90-day mark and an average 90d return of +4.0%, indicating his open-market sales have historically lagged market moves by a narrow margin. This sale occurs with the stock -40.5% from its 52-week high of $328.33 and the company trading at a P/E of 36.38 with strong fundamentals (revenue $16.1B, net income $6.1B, +8.4% annual growth).

Director Berg sells 49.4K ORCL shares ($14.0M) in 4 transactions; stock down 21.8% from 52-week high.

Jeffrey Berg (Director) executed 4 separate sales totaling 49,365 shares for $13,971,266.67 on 2025-10-28, reducing his holdings from 201,364 to 151,999 shares (-24.5%). The blended average sale price was $283.02, while the current price stands at $256.89, representing a 21.8% decline from the 52-week high of $328.33. Notably, his prior sales at ORCL show a consistent pattern: 0 of 5 prior sells were well-timed at the 90-day mark (average 90d return +12.6%, meaning he sold before subsequent gains). The transaction occurred as Oracle trades at a P/E of 58.65 with recent quarterly fundamentals showing $14.9B in revenue and $2.9B in net income. The absence of a 10b5-1 plan flag indicates this was a discretionary sale.

Oracle CAO Smith sells 10,000 shares in 2 tranches ($2.8M); holds 47.1K post-sale as stock down -14.7% from 52-week high.

Smith Maria, Oracle's Chief Accounting Officer, executed 2 separate sales totaling 10,000 shares for $2,803,122.50 on 2025-10-21 and 2025-10-23 at blended average price of $280.31. This sale reduces her holdings by 17.5% from the 57.1K shares held pre-transaction. Oracle's current stock price of $280.07 is -14.7% from its 52-week high of $328.33 and down -10.8% over the past 30 days, placing the stock in a near-term downtrend despite longer-term strength (90-day return +14.3%). At the same ticker, Smith's prior 2 sells (2025-07-03 and 2024-09-16) showed 90-day post-sale returns of +24.0% and +5.1% respectively—both positive outcomes, indicating a 0% well-timed rate at Oracle historically. The timing context shows Oracle trading well below its recent highs amid near-term weakness, with Smith retaining a substantial 47.1K share position post-transaction.

Oracle CEO Clayton Magouyrk sold 40,000 shares for $11.1M at $276.64 on 2025-10-21; holds 154,030 shares post-sale.

Oracle CEO Clayton Magouyrk sold 40,000 shares (40.0K shares) of ORCL at $276.64 on 2025-10-21 for $11,065,508.00 ($11.1M), reducing his holdings by 20.6% to 154,030 shares (154.0K shares). The sale occurred at a price -14.7% from the 52-week high of $328.33, during a 30-day downtrend of -10.8%. His cross-ticker track record shows prior sells with an average 90-day return of +41.1%, indicating those sales were poorly timed (stock rose after); at Oracle specifically, his prior two sales (2025-09-12 and 2025-06-17) did not establish a pattern of well-timed selling (0 of 1 measurable outcomes were well-timed). The company fundamentals remain solid: $14.9B in latest quarterly revenue, $2.9B net income, and 8.4% annual revenue growth, though the 63.94 P/E suggests premium valuation.

Oracle CLO Levey Stuart sold 19,758 shares at $300.00 on 2025-10-10, reducing holdings by -51.7%, for $5,927,400.00 total value.

Levey Stuart, EVP and Chief Legal Officer of Oracle, executed a substantial liquidation of his shareholding, disposing of 19,758 shares at $300.00 per share and cutting his position from 38,187 shares to 18,429 shares. The magnitude of the reduction—-51.7% of prior holdings—reflects a significant rebalancing of his investment exposure in a company where he serves in a senior executive role. The stock is currently trading at $299.00, -8.9% from its 52-week high of $328.33, and has appreciated 23.9% over the past 90 days, providing context for the price at which the sale occurred. Oracle's fundamentals remain solid, with $14.9B in latest-quarter revenue, $2.9B net income, and 8.4% annual revenue growth, though the elevated P/E of 68.26 reflects market expectations already pricing in considerable growth.

Oracle President Michael D. Sicilia sells 33,845 shares (33.8K) for $10.9M on 2025-09-23; holdings drop 20.3% to 132.7K shares post-transaction

Michael D. Sicilia, President of Industries at Oracle, executed a sale of 33,845 shares (33.8K shares) at $321.16 on 2025-09-23, reducing his stake by 20.3% to 132,656 shares (132.7K shares) post-transaction. The sale occurs as ORCL stock trades near its 52-week high (currently $313.83, or -4.4% from the $328.33 peak) and after a strong 30-day run (+32.8%) and 90-day rally (+48.9%), though without scheduled-trade context, timing characterization cannot be definitively applied. Sicilia's cross-ticker track record shows 2 prior open-market sells with an average 30-day return of -12.4%, while his prior ORCL sales in the same window (2025-09-16 and 2025-08-05) are still relatively recent with limited measurable outcomes; the August sale shows a 30-day return of -12.4%, tracking with his broader pattern. The magnitude of the reduction—20.3% of pre-transaction holdings—represents a material portfolio shift that merits observation, particularly given Oracle's elevated valuation (P/E of 71.65) and the stock's recent appreciation momentum.